Go Pro

Adicet Bio (ACET) Competitors

Adicet Bio logo
$8.22 -0.46 (-5.30%)
Closing price 04:00 PM Eastern
Extended Trading
$8.20 -0.02 (-0.18%)
As of 07:36 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

ACET vs. ADMA, URI, GWW, FAST, and WCC

Should you buy Adicet Bio stock or one of its competitors? MarketBeat compares Adicet Bio with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Adicet Bio include ADMA Biologics (ADMA), United Rentals (URI), W.W. Grainger (GWW), Fastenal (FAST), and WESCO International (WCC).

How does Adicet Bio compare to ADMA Biologics?

ADMA Biologics (NASDAQ:ADMA) and Adicet Bio (NASDAQ:ACET) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, earnings, profitability, analyst recommendations, risk, media sentiment, institutional ownership and valuation.

ADMA Biologics has higher revenue and earnings than Adicet Bio. Adicet Bio is trading at a lower price-to-earnings ratio than ADMA Biologics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ADMA Biologics$510.17M4.00$146.93M$0.6812.96
Adicet BioN/AN/A-$116.80M-$14.90N/A

ADMA Biologics has a beta of 0.73, indicating that its share price is 27% less volatile than the broader market. Comparatively, Adicet Bio has a beta of 1.58, indicating that its share price is 58% more volatile than the broader market.

ADMA Biologics presently has a consensus target price of $18.67, indicating a potential upside of 111.88%. Adicet Bio has a consensus target price of $48.80, indicating a potential upside of 493.67%. Given Adicet Bio's stronger consensus rating and higher possible upside, analysts plainly believe Adicet Bio is more favorable than ADMA Biologics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ADMA Biologics
0 Sell rating(s)
3 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.50
Adicet Bio
1 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.75

ADMA Biologics has a net margin of 32.43% compared to Adicet Bio's net margin of 0.00%. ADMA Biologics' return on equity of 39.98% beat Adicet Bio's return on equity.

Company Net Margins Return on Equity Return on Assets
ADMA Biologics32.43% 39.98% 28.08%
Adicet Bio N/A -80.35%-65.44%

75.7% of ADMA Biologics shares are held by institutional investors. Comparatively, 83.9% of Adicet Bio shares are held by institutional investors. 3.9% of ADMA Biologics shares are held by insiders. Comparatively, 3.4% of Adicet Bio shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, ADMA Biologics had 31 more articles in the media than Adicet Bio. MarketBeat recorded 35 mentions for ADMA Biologics and 4 mentions for Adicet Bio. Adicet Bio's average media sentiment score of 0.86 beat ADMA Biologics' score of 0.04 indicating that Adicet Bio is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
ADMA Biologics
1 Very Positive mention(s)
0 Positive mention(s)
33 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Adicet Bio
0 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

ADMA Biologics beats Adicet Bio on 9 of the 16 factors compared between the two stocks.

How does Adicet Bio compare to United Rentals?

Adicet Bio (NASDAQ:ACET) and United Rentals (NYSE:URI) are both trading companies & distributors companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, media sentiment, dividends, valuation, risk, profitability and institutional ownership.

Adicet Bio currently has a consensus price target of $48.80, indicating a potential upside of 493.67%. United Rentals has a consensus price target of $1,131.56, indicating a potential upside of 5.40%. Given Adicet Bio's higher probable upside, equities research analysts clearly believe Adicet Bio is more favorable than United Rentals.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Adicet Bio
1 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.75
United Rentals
1 Sell rating(s)
1 Hold rating(s)
14 Buy rating(s)
0 Strong Buy rating(s)
2.81

United Rentals has higher revenue and earnings than Adicet Bio. Adicet Bio is trading at a lower price-to-earnings ratio than United Rentals, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Adicet BioN/AN/A-$116.80M-$14.90N/A
United Rentals$16.10B4.18$2.49B$39.2027.39

United Rentals has a net margin of 15.32% compared to Adicet Bio's net margin of 0.00%. United Rentals' return on equity of 30.56% beat Adicet Bio's return on equity.

Company Net Margins Return on Equity Return on Assets
Adicet BioN/A -80.35% -65.44%
United Rentals 15.32%30.56%9.23%

Adicet Bio has a beta of 1.58, meaning that its stock price is 58% more volatile than the broader market. Comparatively, United Rentals has a beta of 1.79, meaning that its stock price is 79% more volatile than the broader market.

83.9% of Adicet Bio shares are held by institutional investors. Comparatively, 96.3% of United Rentals shares are held by institutional investors. 3.4% of Adicet Bio shares are held by insiders. Comparatively, 0.5% of United Rentals shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, United Rentals had 14 more articles in the media than Adicet Bio. MarketBeat recorded 18 mentions for United Rentals and 4 mentions for Adicet Bio. United Rentals' average media sentiment score of 1.33 beat Adicet Bio's score of 0.86 indicating that United Rentals is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Adicet Bio
0 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
United Rentals
13 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

United Rentals beats Adicet Bio on 13 of the 16 factors compared between the two stocks.

How does Adicet Bio compare to W.W. Grainger?

W.W. Grainger (NYSE:GWW) and Adicet Bio (NASDAQ:ACET) are both trading companies & distributors companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, valuation, media sentiment, analyst recommendations, profitability, earnings, dividends and institutional ownership.

W.W. Grainger has a net margin of 9.70% compared to Adicet Bio's net margin of 0.00%. W.W. Grainger's return on equity of 47.87% beat Adicet Bio's return on equity.

Company Net Margins Return on Equity Return on Assets
W.W. Grainger9.70% 47.87% 21.84%
Adicet Bio N/A -80.35%-65.44%

W.W. Grainger has a beta of 1.03, suggesting that its stock price is 3% more volatile than the broader market. Comparatively, Adicet Bio has a beta of 1.58, suggesting that its stock price is 58% more volatile than the broader market.

W.W. Grainger has higher revenue and earnings than Adicet Bio. Adicet Bio is trading at a lower price-to-earnings ratio than W.W. Grainger, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
W.W. Grainger$17.94B3.68$1.71B$37.1837.64
Adicet BioN/AN/A-$116.80M-$14.90N/A

80.7% of W.W. Grainger shares are owned by institutional investors. Comparatively, 83.9% of Adicet Bio shares are owned by institutional investors. 6.3% of W.W. Grainger shares are owned by insiders. Comparatively, 3.4% of Adicet Bio shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

W.W. Grainger currently has a consensus target price of $1,230.11, indicating a potential downside of 12.09%. Adicet Bio has a consensus target price of $48.80, indicating a potential upside of 493.67%. Given Adicet Bio's stronger consensus rating and higher probable upside, analysts clearly believe Adicet Bio is more favorable than W.W. Grainger.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
W.W. Grainger
1 Sell rating(s)
8 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.09
Adicet Bio
1 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.75

In the previous week, W.W. Grainger had 18 more articles in the media than Adicet Bio. MarketBeat recorded 22 mentions for W.W. Grainger and 4 mentions for Adicet Bio. Adicet Bio's average media sentiment score of 0.86 beat W.W. Grainger's score of 0.77 indicating that Adicet Bio is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
W.W. Grainger
9 Very Positive mention(s)
4 Positive mention(s)
3 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive
Adicet Bio
0 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

W.W. Grainger beats Adicet Bio on 9 of the 16 factors compared between the two stocks.

How does Adicet Bio compare to Fastenal?

Adicet Bio (NASDAQ:ACET) and Fastenal (NASDAQ:FAST) are both trading companies & distributors companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, media sentiment, profitability, valuation, institutional ownership, dividends, risk and analyst recommendations.

Adicet Bio currently has a consensus target price of $48.80, suggesting a potential upside of 493.67%. Fastenal has a consensus target price of $48.83, suggesting a potential upside of 4.64%. Given Adicet Bio's stronger consensus rating and higher probable upside, analysts plainly believe Adicet Bio is more favorable than Fastenal.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Adicet Bio
1 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.75
Fastenal
2 Sell rating(s)
6 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.23

Adicet Bio has a beta of 1.58, meaning that its stock price is 58% more volatile than the broader market. Comparatively, Fastenal has a beta of 0.72, meaning that its stock price is 28% less volatile than the broader market.

In the previous week, Fastenal had 44 more articles in the media than Adicet Bio. MarketBeat recorded 48 mentions for Fastenal and 4 mentions for Adicet Bio. Adicet Bio's average media sentiment score of 0.86 beat Fastenal's score of 0.81 indicating that Adicet Bio is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Adicet Bio
0 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Fastenal
19 Very Positive mention(s)
4 Positive mention(s)
16 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive

Fastenal has higher revenue and earnings than Adicet Bio. Adicet Bio is trading at a lower price-to-earnings ratio than Fastenal, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Adicet BioN/AN/A-$116.80M-$14.90N/A
Fastenal$8.20B6.53$1.26B$1.1440.94

83.9% of Adicet Bio shares are held by institutional investors. Comparatively, 81.4% of Fastenal shares are held by institutional investors. 3.4% of Adicet Bio shares are held by company insiders. Comparatively, 0.3% of Fastenal shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Fastenal has a net margin of 15.45% compared to Adicet Bio's net margin of 0.00%. Fastenal's return on equity of 34.03% beat Adicet Bio's return on equity.

Company Net Margins Return on Equity Return on Assets
Adicet BioN/A -80.35% -65.44%
Fastenal 15.45%34.03%26.16%

Summary

Fastenal beats Adicet Bio on 8 of the 15 factors compared between the two stocks.

How does Adicet Bio compare to WESCO International?

WESCO International (NYSE:WCC) and Adicet Bio (NASDAQ:ACET) are both trading companies & distributors companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, risk, earnings, valuation, analyst recommendations, media sentiment, dividends and institutional ownership.

WESCO International presently has a consensus target price of $341.22, indicating a potential upside of 4.38%. Adicet Bio has a consensus target price of $48.80, indicating a potential upside of 493.67%. Given Adicet Bio's higher probable upside, analysts clearly believe Adicet Bio is more favorable than WESCO International.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
WESCO International
0 Sell rating(s)
0 Hold rating(s)
9 Buy rating(s)
1 Strong Buy rating(s)
3.10
Adicet Bio
1 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.75

In the previous week, WESCO International had 4 more articles in the media than Adicet Bio. MarketBeat recorded 8 mentions for WESCO International and 4 mentions for Adicet Bio. Adicet Bio's average media sentiment score of 0.86 beat WESCO International's score of 0.57 indicating that Adicet Bio is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
WESCO International
2 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Adicet Bio
0 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

WESCO International has a beta of 1.54, suggesting that its share price is 54% more volatile than the broader market. Comparatively, Adicet Bio has a beta of 1.58, suggesting that its share price is 58% more volatile than the broader market.

WESCO International has higher revenue and earnings than Adicet Bio. Adicet Bio is trading at a lower price-to-earnings ratio than WESCO International, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
WESCO International$23.51B0.68$640.20M$14.0723.23
Adicet BioN/AN/A-$116.80M-$14.90N/A

WESCO International has a net margin of 2.79% compared to Adicet Bio's net margin of 0.00%. WESCO International's return on equity of 13.82% beat Adicet Bio's return on equity.

Company Net Margins Return on Equity Return on Assets
WESCO International2.79% 13.82% 4.12%
Adicet Bio N/A -80.35%-65.44%

93.8% of WESCO International shares are owned by institutional investors. Comparatively, 83.9% of Adicet Bio shares are owned by institutional investors. 2.6% of WESCO International shares are owned by company insiders. Comparatively, 3.4% of Adicet Bio shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

WESCO International beats Adicet Bio on 11 of the 15 factors compared between the two stocks.

Get Adicet Bio News Delivered to You Automatically

Sign up to receive the latest news and ratings for ACET and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ACET and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ACET vs. The Competition

MetricAdicet BioMED IndustryMedical SectorNASDAQ Exchange
Market Cap$81.14M$3.68B$6.85B$12.45B
Dividend YieldN/A2.22%2.68%9.43%
P/E Ratio-0.5521.2527.2124.25
Price / SalesN/A174.07510.3787.30
Price / CashN/A143.8948.6360.03
Price / Book0.498.3910.786.23
Net Income-$116.80M$23.83M$3.59B$331.94M
7 Day Performance-8.05%-5.21%-2.55%-1.93%
1 Month Performance5.93%5.32%2.81%-0.97%
1 Year Performance-34.13%45.75%25.42%18.24%

Adicet Bio Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ACET
Adicet Bio
2.7701 of 5 stars
$8.22
-5.3%
$48.80
+493.7%
-28.8%$81.14MN/AN/A90
ADMA
ADMA Biologics
4.4722 of 5 stars
$8.97
-1.2%
$19.67
+119.2%
-51.7%$2.10B$510.17M13.19530
URI
United Rentals
4.0662 of 5 stars
$1,085.53
-0.9%
$1,127.81
+3.9%
+31.1%$68.63B$16.10B27.6928,500
GWW
W.W. Grainger
4.1097 of 5 stars
$1,391.17
+1.1%
$1,216.44
-12.6%
+31.6%$64.95B$17.94B37.4222,100
FAST
Fastenal
4.0443 of 5 stars
$47.05
+1.2%
$48.31
+2.7%
+0.5%$53.37B$8.20B41.2724,489

Related Companies and Tools


This page (NASDAQ:ACET) was last updated on 7/16/2026 by MarketBeat.com Staff.
From Our Partners